AI Trial Design Leverage Phesi’s AI-enabled trial design and predictive analytics to help sponsors shorten development timelines and optimize trial protocols. Use AI trial simulation to compare scenarios, justify site and CRO choices, and accelerate decision making; position Phesi as a fast, data-driven partner for mid to late stage programs.

Site Optimization Self-service Investigator Site Profile enables filtering out non-active and non-enrolling sites, presenting a clear opportunity to sell site optimization, enrollment forecasting, and site monitoring services to sponsors and CROs. Recommend pilots for trials with slow enrollment to demonstrate ROI and reduce screening costs.

Patient Burden Score Predictive Patient Burden Score addresses patient experience and enrollment efficiency, offering an upsell for patient-centric trial design and enrollment optimization. Focus on trials with high dropout risk and complex patient pathways; propose integration with planning workflows to improve retention and site performance.

Digital Twin Phesi’s digital twin for chronic GVHD demonstrates capability to model disease dynamics and treatment scenarios; use to expand into other indications and risk-based monitoring solutions. Propose co-development pilots with sponsors pursuing complex or rare diseases to validate ROI and scale across programs.

Awards Credibility Recognition from Frost & Sullivan and Clinical Trials Arena highlights credibility and innovation in AI-enabled trial design; use award stories and case studies to shorten sales cycles and win larger pharma and CRO deals. Align messaging with data-driven decision support and measurable ROI.